5 research outputs found

    Different proportion of root cutting and shoot pruning influence the growth of citronella plants

    Get PDF
    Environment concern, sustainable products demand, and natural components conscious are currently global movement factors. Related to the global movement factors, citronella grass (Cymbopogon nardus L.) is being widely used in folk medicine, and has insect repellent activity, fungal and bactericidal action. Its essential oil has high content of citronellal, citronellol, geraniol. The essential oil is mostly extracted from leaves which turns this plant with high commercial demand. However, to obtain the best therapeutic quality and productivity of medicinal plants, which culminates in greater quantity and quality of the active compounds, the proper management of the crop is fundamental, as several factors can interfere during its growth and development. Thus, we analyzed the growth of citronella plants submitted to different levels of shoot and root cuts. Five different proportions of root pruning (0, 25, 50, 75, 100%), after 145 days of seedling planting and four cuttings in the shoots: blunt; a cut at 145 DAP (days after planting) along with the root cut; a cut at 228 DAP; and cuts at 145 and 228 DAP (two cuts). Four harvesting for dry matter accumulation and photoassimilate partition data were performed. The treatment with 100% root cut, but without leaf cut, increased the total dry mass accumulation of the plant in relation to the other treatments, for the last analysis period, demonstrating a recovery. Thus, the application of two leaf cuts or no leaf cutting within the 100% root cut treatment for leaf dry mass accumulation is more effective when compared to the blunt root treatment

    Technical and economic pre-feasibility study for the construction of septic tank-filter-sinkhole with alternative material

    Get PDF
    Received: February 2nd, 2021 ; Accepted: August 3rd, 2021 ; Published: August 24th, 2021 ; Correspondence: [email protected] study of the different materials used in the construction of septic tanks aims to facilitate and spread the use of this sewage treatment system in places that are not assisted by municipal sewage systems and in the rural area, which despite having a smaller number of inhabitants compared to the urban area This study aims to carry out a technical and economic evaluation of the concrete and tires using in the construction of septic tanks-filter-sinkhole. The wastewater treatment systems were built according to the recommendations in NBR 7229/93 and 13969/97. To evaluate the efficiency of each system built, the following parameters were analyzed: chemical oxygen demand (COD), the potential of hydrogen (pH), alkalinity, acidity, and temperature. In the economic evaluation, the materials and labor required to install the systems were considered using the Brazilian cost database (SINAPI), and an economic and financial feasibility study was carried out. According to the technical and economic analysis of construction, both systems showed the same technical performance, however, the concrete design proved to be more advantageous than the tire design, considering the difficulty in acquiring the tires and the high cost if it is necessary to buy them, in addition to the greater difficulty in handling and installing the tire system compared to the concrete one

    Implementation of dihydropyrimidine dehydrogenase deficiency testing in Europe.

    No full text
    BACKGROUND: The main cause for fluoropyrimidine-related toxicity is deficiency of the metabolizing enzyme dihydropyrimidine dehydrogenase (DPD). In 2020, the European Medicines Agency (EMA) recommended two methods for pre-treatment DPD deficiency testing in clinical practice: phenotyping using endogenous uracil concentration or genotyping for DPYD risk variant alleles. This study assessed the DPD testing implementation status in Europe before (2019) and after (2021) the release of the EMA recommendations. METHODS: The survey was conducted from 16 March 2022 to 31 July 2022. An electronic form with seven closed and three open questions was e-mailed to 251 professionals with DPD testing expertise of 34 European countries. A descriptive analysis was conducted. RESULTS: We received 79 responses (31%) from 23 countries. Following publication of the EMA recommendations, 87% and 75% of the countries reported an increase in the amount of genotype and phenotype testing, respectively. Implementation of novel local guidelines was reported by 21 responders (27%). Countries reporting reimbursement of both tests increased in 2021, and only four (18%) countries reported no coverage for any testing type. In 2019, major implementation drivers were 'retrospective assessment of fluoropyrimidine-related toxicity' (39%), and in 2021, testing was driven by 'publication of guidelines' (40%). Although the major hurdles remained the same after EMA recommendations-'lack of reimbursement' (26%; 2019 versus 15%; 2021) and 'lack of recognizing the clinical relevance by medical oncologists' (25%; 2019 versus 8%; 2021)-the percentage of specialists citing these decreased. Following EMA recommendations, 25% of responders reported no hurdles at all in the adoption of the new testing practice in the clinics. CONCLUSIONS: The EMA recommendations have supported the implementation of DPD deficiency testing in Europe. Key factors for successful implementation were test reimbursement and clear clinical guidelines. Further efforts to improve the oncologists' awareness of the clinical relevance of DPD testing in clinical practice are needed
    corecore